Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) - Resource Center (U24 Clinical Trial Not Allowed)

The National Institutes of Health, within the U.S. Department of Health and Human Services, is offering a single-source cooperative agreement funding opportunity titled “Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) - Resource Center.” NIH is the primary federal agency responsible for biomedical and public health research in the United States, and this initiative is aligned with its broader mission to advance scientific knowledge and improve health outcomes. This specific program is administered through the National Institute of Diabetes and Digestive and Kidney Diseases and is associated with the Special Diabetes Program, a congressionally funded initiative supporting research into type 1 diabetes and its complications. The purpose of this funding opportunity is to support the continuation and expansion of the CaRe-T1D Resource Center, which plays a central role in advancing research on cardiovascular disease in individuals with type 1 diabetes. The program focuses on building and maintaining a biorepository of human cardiovascular tissue and associated data, enabling researchers to investigate disease mechanisms, identify differences between type 1 and type 2 diabetes, and contribute to the development of targeted therapies. The Resource Center is also expected to enhance data-sharing infrastructure, including the development of data commons and artificial intelligence tools, and to coordinate collaborative research efforts across the CaRe-T1D consortium. Funding under this opportunity is structured as a cooperative agreement, indicating substantial involvement from NIH staff in project oversight and collaboration. The estimated total program funding is $2,000,000, with an award ceiling of $1,500,000. Only one award is expected to be made. There is no cost sharing or matching requirement associated with this opportunity. Funds are intended to support activities such as repository expansion, data infrastructure development, coordination of consortium activities, and facilitation of access to resources for the broader research community. Eligibility for this opportunity is highly restricted due to its designation as a single-source competition. While the general eligibility categories listed include a wide range of entities such as higher education institutions, nonprofits, government entities, and for-profit organizations, the Additional Information on Eligibility explicitly states that only the University of Florida is eligible to apply. Furthermore, foreign organizations and foreign components of U.S. organizations are not permitted to participate in this funding opportunity. Applications must be submitted through the standard NIH grants process and will undergo peer review in accordance with NIH policies. Only applications deemed meritorious through this review process will be considered for funding. The submission deadline for applications is September 30, 2026. There are no pre-application requirements such as letters of intent specified in the provided materials. Applicants must follow NIH submission protocols, which typically include detailed research plans, budget justifications, and supporting documentation. The timeline for this opportunity includes a posting date of June 4, 2026, and a closing date of September 30, 2026. The archive date is November 29, 2026. While no explicit award notification date or project start date is provided, NIH cooperative agreements generally follow a structured review and funding cycle. This opportunity does not indicate recurring availability and is intended as a continuation of an existing program through a single eligible applicant. For further information or assistance, applicants may contact the NIDDK Division of Diabetes, Endocrinology and Metabolic Diseases via email at NIDDK_DEM@nih.gov.